BioHealth News Archive
American Gene Technologies Gets Go-Ahead to Test Possible HIV Cure | BioSpace
HIV therapies, typically cocktails of antiviral drugs, have proven to be very successful in controlling HIV/AIDS. However, they are not a “cure,” which is…
Read MoreEmergent BioSolutions Teams Up with Boston Red Sox, Cincinnati Reds, Philadelphia Phillies, and MAPDA to Highlight Importance of Overdose Reversal Medicines on International Overdose Awareness Day | BioSpace
GAITHERSBURG, Md., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it is teaming up with the Boston Red…
Read MoreDevelopment of COVID-19 vaccine AZD1222 expands into US Phase III clinical trial across all adult age groups – Vaccitech
Vaccitech Ltd, a clinical-stage biopharmaceutical company developing immunotherapies to treat and prevent infectious diseases and cancer, announces that the development of AstraZeneca’s AZD1222 vaccine…
Read MoreJonathan DeCarlo Named Chief Financial Officer at Emmes
ROCKVILLE, Md., Sept. 1, 2020 /PRNewswire/ -- Emmes today announced that Jonathan DeCarlo has been promoted to chief financial officer. DeCarlo, who has served as…
Read MoreJohns Hopkins University Giving Wellness Kits To Undergrads To Protect Against COVID-19 – CBS Baltimore
BALTIMORE (WJZ) — As the fall semester begins, Johns Hopkins University wants to make sure its students are protected. They are giving out wellness…
Read MoreITI Announces Publication of Results from 3 ATTAC Studies of CMV-Specific Dendritic Cell Vaccines for the Treatment of GBM – Immunomic Therapeutics
ROCKVILLE, Md. & SAN DIEGO–(BUSINESS WIRE)–Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced today…
Read More5th Annual BioHealth Capital Region (BHCR) Crab Trap Competition
Don't miss your change to be named the BioHealth Startup with the Most Commectial Potential at the BHCR Forum, win $10,000 and more! …
Read MoreUnique Team-Building and Promotion for your BioHealth Company: FRAXA Biotech Games™ for Research – Register Now. Games Begin This Thursday Sept. 10th
Are you seeking an opportunity to engage your firm in a fun community-building activity? Register one or more teams for the FRAXA Biotech Games. …
Read MoreCartesian Therapeutics Initiates Clinical Trial of First RNA-Engineered Cell Therapy for Acute Respiratory Distress Syndrome and COVID-19 – Cartesian
Gaithersburg, MD, September 1, 2020 – Cartesian Therapeutics, a fully integrated, clinical-stage biopharmaceutical company developing cell and gene therapies for cancer, autoimmune diseases and…
Read MoreOxiWear rushes to get wearable oxygen monitor to Covid-19 patients – Washington Business Journal
OxiWear's own founder is a user herself of its oxygen monitor for patients with severe pulmonary hypertension. Image: Shavini Fernando is founder and CEO…
Read MoreEconomic Alliance of Greater Baltimore (EAGB), President and CEO, Michele L. Whelley, Joins Rich Bendis on BioTalk
Economic Alliance of Greater Baltimore (EAGB), President and CEO, Michele L. Whelley, joins BioTalk to discuss her career, the economic development environment in Baltimore,…
Read MoreNovavax and Canada Reach Agreement in Principle to Acquire Novavax’ COVID-19 Vaccine | Novavax Inc. – IR Site
GAITHERSBURG, Md., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases,…
Read MoreHampton Roads accelerator program goes virtual amid pandemic – The Virginian-Pilot – Inside Business
Imagine being able to use science to choose the right music for an advertising campaign or being able to order food and groceries on…
Read MoreREGENXBIO Announces FDA Clearance of IND for Phase II Trial of RGX-314 for the Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery | BioSpace
ROCKVILLE, Md., Aug. 25, 2020 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential…
Read MoreArcellx Announces EvansMDS Grant Awarded for Collaboration with Johns Hopkins and University of Colorado Researchers to Support Development of Arcellx ARC-sparX Platform Candidate ACLX-002
GAITHERSBURG, Md., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Arcellx today announced the award of an EvansMDS Discovery Research Grant to Johns Hopkins University to…
Read More